Table 3.
Molecular docking of selective components with pathway proteins
| Compound | IKB-α | JNK | p50 | p65 | p38 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Human | Mice | Human | Mice | Human | Mice | Human | Mice | Human | Mice | |
| Linalyl acetate | -4.1 | -4.3 | -6.3 | -6.3 | -5.8 | -5.2 | -5.0 | -4.7 | -5.5 | -5.6 |
| linalool | -3.9 | -4.2 | -5.6 | -5.2 | -5.8 | -5.2 | -5.0 | -4.6 | -5.1 | -5.2 |
| Lavandulol acetate | -4.2 | -4.4 | -6.4 | -6.2 | -6.2 | -5.6 | -5.2 | -5.1 | -5.8 | -5.7 |
| cis-β-Ocimene | -3.9 | -4.1 | -6.2 | -5.7 | -5.8 | -5.0 | -5.0 | -4.4 | -5.2 | -4.7 |
| 1-Octen-3-yl-acetate | -3.8 | -3.9 | -5.6 | -5.4 | -5.1 | -4.6 | -4.6 | -4.3 | -5.0 | -5.1 |
| Caryophyllene | -4.9 | -4.9 | -7.2 | -7.5 | -6.0 | -6.0 | -6.1 | -5.4 | -7.1 | -7.2 |
| Terpinen-4-ol | -4.2 | -4.5 | -6.1 | -5.5 | -6.0 | -5.1 | -5.3 | -5.0 | -5.6 | -5.5 |
| (4E,6E)-Alloocimene | -4.2 | -4.3 | -6.5 | -6.0 | -6.1 | -5.1 | -5.5 | -4.8 | -5.2 | -5.3 |
| β-Ocimene | -4.0 | -4.0 | -6.4 | -5.9 | -5.8 | -4.5 | -4.9 | -4.6 | -5.1 | -4.9 |
| Geranyl acetate | -4.5 | -4.4 | -6.7 | -6.4 | -6.1 | -5.2 | -5.6 | -4.6 | -5.8 | -5.7 |
| β-Myrcene | -4.0 | -4.2 | -6.1 | -5.6 | -5.6 | -4.9 | -4.9 | -4.2 | -5.0 | -4.8 |